Detalles de la búsqueda
1.
Anti-PD-1 alone or in combination with anti-CTLA-4 for advanced melanoma patients with liver metastases.
Eur J Cancer;
205: 114101, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38735161
2.
Tolerability of Narrow-band Ultraviolet-B Phototherapy for Different Dermatological Diseases in Relation to Co-medications.
Acta Derm Venereol;
104: adv35215, 2024 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38567914
3.
Patients' and dermatologists' preferences in artificial intelligence-driven skin cancer diagnostics: A prospective multicentric survey study.
J Am Acad Dermatol;
2024 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38670313
4.
C-reactive protein flare predicts response to checkpoint inhibitor treatment in melanoma.
J Eur Acad Dermatol Venereol;
2024 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38466133
5.
Effects of an immunosuppressive therapy on the efficacy of immune checkpoint inhibition in metastatic melanoma - An analysis of the prospective skin cancer registry ADOREG.
Eur J Cancer;
198: 113508, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38183763
6.
S3-Leitlinie "Aktinische Keratose und Plattenepithelkarzinom der Haut" - Update 2023, Teil 2: Epidemiologie und Ätiologie, Diagnostik, Therapie des invasiven Plattenepithelkarzinoms der Haut, Nachsorge und Prävention: S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma" - update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention.
J Dtsch Dermatol Ges;
21(11): 1422-1434, 2023 11.
Artículo
en Alemán
| MEDLINE | ID: mdl-37946644
7.
S3-Leitlinie "Aktinische Keratose und Plattenepithelkarzinom der Haut" - Update 2023, Teil 1: Therapie der aktinischen Keratose, Morbus Bowen, Cheilitis actinica, berufsbedingte Erkrankung und Versorgungsstrukturen: S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma"- update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of care.
J Dtsch Dermatol Ges;
21(10): 1249-1262, 2023 10.
Artículo
en Alemán
| MEDLINE | ID: mdl-37845050
8.
S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma"- update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of care.
J Dtsch Dermatol Ges;
21(10): 1249-1262, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37845077
9.
S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma" - update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention.
J Dtsch Dermatol Ges;
21(11): 1422-1433, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37840404
10.
Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma - analysis of the DeCOG prospective multicenter cohort study ADOREG/TRIM.
EBioMedicine;
96: 104774, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37660535
11.
Treatment management for BRAF-mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREG.
J Immunother Cancer;
11(9)2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37730278
12.
COMBI-r: A Prospective, Non-Interventional Study of Dabrafenib Plus Trametinib in Unselected Patients with Unresectable or Metastatic BRAF V600-Mutant Melanoma.
Cancers (Basel);
15(18)2023 Sep 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37760406
13.
Liver-directed treatment is associated with improved survival and increased response to immune checkpoint blockade in metastatic uveal melanoma: results from a retrospective multicenter trial.
Front Med;
17(5): 878-888, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37432641
14.
9. Virtuelles Netzwerktreffen der zertifizierten Hautkrebszentren 26./27.01.2023.
J Dtsch Dermatol Ges;
21(6): 706-708, 2023 06.
Artículo
en Alemán
| MEDLINE | ID: mdl-37338844
15.
Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG.
Eur J Cancer;
188: 140-151, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37245442
16.
Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG.
J Immunother Cancer;
11(4)2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37028819
17.
Characterisation and outcome of RAC1 mutated melanoma.
Eur J Cancer;
183: 1-10, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36773463
18.
Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg Registry.
Cancers (Basel);
14(22)2022 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36428636
19.
Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma: a multicenter study of the prospective skin cancer registry ADOREG.
J Immunother Cancer;
10(11)2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36450381
20.
Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma.
J Immunother Cancer;
10(7)2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35793872